Details About Generic Salt ::  Oxacilli

Main Medicine Class:: Antibiotic, Penicillin   

(ox-uh-SILL-in SO-dee-uhm)
Oxacillin Sodium
Powder for oral solution: 250 mg/5 mL
Powder for injection: 500 mg
Powder for injection: 1 g
Powder for injection: 2 g
Powder for injection: 10 g
Class: Antibiotic, Penicillin

 

Drugs Class ::

 Action Inhibits mucopeptide synthesis in bacterial cell wall.

Indications for Drugs ::

 Indications Treatment of infections caused by penicillinase-producing staphylococci; initial therapy of suspected staphylococcal infection.

Drug Dose ::

 Route/Dosage

Adults: PO/IV/IM 250 mg to 1 g q 4 to 6 hr. Children (less than 40 kg): PO/IV/IM 50 to 100 mg/kg/day in divided doses q 4 to 6 hr. Premature/Neonates: IV/IM 25 mg/kg/day.

Contraindication ::

 Contraindications Hypersensitivity to penicillins. Do not treat severe pneumonia, empyema, bacteremia, pericarditis, meningitis and purulent or septic arthritis with oral oxacillin during acute state.

Drug Precautions ::

 Precautions

Pregnancy: Category B. Lactation: Excreted in breast milk. Hypersensitivity: Reactions range from mild to life-threatening. Administer cautiously to cephalosporin-sensitive or imipenem-sensitive patients because of possible crossreactivity. Pseudomembranous colitis: Consider pseudomembranous colitis in patients who develop diarrhea. Sodium content: Contains 2.5 to 3.1 mEq sodium/g. Superinfection: May result in bacterial or fungal overgrowth of nonsusceptible organisms.

PATIENT CARE CONSIDERATIONS


Drug Side Effects ::

 Adverse Reactions

CNS: Neurotoxicity (eg, lethargy, neuromuscular irritability, hallucinations, convulsions and seizures); dizziness; fatigue; insomnia; reversible hyperactivity; prolonged muscle relaxation. DERMATOLOGIC: Ecchymosis. EENT: Itchy eyes; abnormal taste perception. GI: Glossitis; stomatitis; gastritis; sore mouth or tongue; dry mouth; furry tongue; black “hairy” tongue; nausea; anorexia; vomiting; abdominal pain or cramp; diarrhea or bloody diarrhea; rectal bleeding; flatulence; enterocolitis; pseudomembranous colitis; anorexia. GU: Interstitial nephritis (eg, oliguria, proteinuria, hematuria, hyaline casts, pyuria); nephropathy; increased creatinine and BUN; vaginitis. HEMATOLOGIC: Deep vein thrombosis; hematomas; phlebitis; anemias; thrombocytopenia; eosinophilia; leukopenia; granulocytopenia; neutropenia; bone marrow depression; agranulocytosis; reduced Hgb or Hct; prolongation of bleeding and prothrombin time. HEPATIC: Transient hepatitis; cholestatic jaundice; increased LFT results. METABOLIC: Elevated serum alkaline phosphatase, AST, ALT, bilirubin, and LDH; hypernatremia; hypokalemia; reduced albumin, total proteins, and uric acid. OTHER: Hypersensitivity reactions that may lead to death; hyperthermia; pain at site of injection; hyperthermia; sciatic neuritis.

Drug Mode of Action ::  

 Action Inhibits mucopeptide synthesis in bacterial cell wall.

Drug Interactions ::

 Interactions

Contraceptives, oral: Reduced efficacy of oral contraceptives. Probenecid: Increased oxacillin levels. Tetracyclines: Impaired bactericidal effects of oxacillin. Aminoglycosides.

Drug Assesment ::

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Ensure that specimens for culture and sensitivity have been obtained before starting therapy.
  • Assess for infection at beginning and throughout course of therapy (eg, fever, appearance of wound, increased WBC).
  • Observe patient for signs and symptoms of anaphylaxis (eg, rash, pruritis, laryngeal edema, wheezing). Discontinue drug if these symptoms occur.
  • Keep resuscitation equipment, adrenaline, and antihistamines available.
  • Notify health care provider if unusual bleeding or bruising occurs.
OVERDOSAGE: SIGNS & SYMPTOMS
  Neuromuscular hyperexcitability, stupor, agitation, confusion, asterixis, hallucinations, coma, multifocal myoclonus, seizures, encephalopathy

Drug Storage/Management ::

 Administration/Storage

  • Administer at regular intervals around the clock.
  • Administer oral doses on empty stomach at least 1 hr before or 2 hr after meals.
  • Reconstitute IM preparation to dilution of 250 mg/1.5 mL. Use deep, slow injection. Rotate sites to prevent tissue irritation.
  • Reconstitute IV preparation with Sterile Water for Injection or Sodium Chloride for Injection. Administer slowly over approximately 10 min to prevent vein irritation.
  • IM solution is stable for up to 3 days at room temperature or 7 days under refrigeration.
  • IV solutions are stable for at least 6 hr at room temperature.
  • Reconstituted oral solution is stable for 14 days if refrigerated.

Drug Notes ::

 Patient/Family Education

  • Advise patient to complete full course of therapy, even if symptoms abate, to prevent reoccurrence of infection.
  • Instruct patient to discard any liquid forms of medication after 7 days if stored at room temperature; after 14 days if refrigerated.
  • Instruct patient to notify health care provider if symptoms of infection do not improve.
  • Advise patient to report puritus and rash immediately.
  • Instruct patient to report the following signs of superinfection: black, “furry” tongue, loose or foul-smelling stools, vaginal itching, discharge.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.